Together with canonical Smad signaling,13 non‐Smad signaling contributes to TGF‐β‐induced EMT, autoinduction, invasiveness, chemoresistance, and immunomodulation in late‐stage cancer. This evidence concerns the gene TGFB1 and cancer.